- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 495/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 495/14
Total number of patents in this class: 1111
10-year publication summary
78
|
77
|
97
|
100
|
96
|
88
|
84
|
83
|
80
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Dana-Farber Cancer Institute, Inc. | 2531 |
52 |
Merck Patent GmbH | 5849 |
44 |
FUJIFILM Corporation | 28467 |
29 |
Bristol-myers Squibb Company | 4886 |
24 |
Sumitomo Chemical Company, Limited | 8966 |
20 |
Duk San Neolux Co., Ltd. | 586 |
20 |
Vanderbilt University | 1811 |
20 |
Incyte Holdings Corporation | 652 |
15 |
Boehringer Ingelheim International GmbH | 4762 |
14 |
The Regents of the University of Michigan | 4570 |
14 |
F. Hoffmann-La Roche AG | 7942 |
13 |
Genentech, Inc. | 3864 |
13 |
Hoffmann-La Roche Inc. | 3252 |
12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2827 |
12 |
Novartis AG | 11297 |
11 |
Samsung Electronics Co., Ltd. | 138320 |
11 |
LG Chem, Ltd. | 17620 |
11 |
The University of Tokyo | 4051 |
11 |
Idemitsu Kosan Co., Ltd. | 4105 |
10 |
Medshine Discovery Inc. | 610 |
10 |
Other owners | 745 |